Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kathiresan Sekar
Relationship:   Chief Executive Office...
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   317,839    

Indirect Shares

  321,994      
Direct Value   $0    

Indirect Value

  $0      
Total Shares   639,833      
Total Value   $0      


Verve Therapeutics, Inc.
 $0 Verve Therapeutics, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Verve Therapeutics, Inc. VERV Chief Executive Office... 2022-10-03 317,839 2022-10-03 321,994    Premium*  
* Premium Members only  

Records found :    20         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-10-03 4 AS $33.02 $1,682,622 D/D (50,000) 317,839 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-10-03 4 OE $1.39 $69,500 D/D 50,000 367,839 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-08-10 4 AS $29.90 $1,495,000 D/D (50,000) 317,839 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-08-10 4 OE $1.39 $69,500 D/D 50,000 367,839 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-07-19 4 OE $1.39 $69,500 D/D 50,000 367,839 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-07-19 4 AS $29.90 $1,495,000 D/D (50,000) 317,839 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-07-07 4 GD $0.00 $0 D/D 160,000 317,839 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-07-07 4 GA $0.00 $0 I/I 160,000 240,997 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-03-18 4 OE $2.87 $199,964 D/D 69,674 477,525 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-01-04 4 AS $39.90 $74,613 D/D (1,870) 406,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-01-04 4 OE $1.39 $2,599 D/D 1,870 408,406 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-28 4 AS $39.90 $267,051 D/D (6,693) 406,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-28 4 OE $1.39 $9,303 D/D 6,693 413,229 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-27 4 AS $40.02 $1,688,484 D/D (42,000) 406,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-27 4 OE $1.39 $58,380 D/D 42,000 448,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-23 4 OE $1.39 $79,230 D/D 57,000 463,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-23 4 AS $39.90 $2,274,300 D/D (57,000) 406,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-22 4 AS $37.38 $2,206,304 D/D (57,000) 406,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-22 4 OE $1.39 $79,230 D/D 57,000 463,536 0 -
VERV Verve Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-06-21 4 B $19.00 $47,500 D/D 2,500 406,536 2.81 -

  20  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed